A major step toward simpler drug development has been taken at the University of Gothenburg. In a new study, researchers have developed stable boron-fluorine compounds that make it possible to ...
New treatments based on biological molecules like RNA give scientists unprecedented control over how cells function. But ...
DS-9606 was supposed to be the first antibody-drug conjugate in Daiichi Sankyo’s line of anti-cancer assets to use a modified pyrrolobenzodiazepine payload.
The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to ...
Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
The FDA and EMA have aligned on ten guiding principles for the responsible use of artificial intelligence across the drug development lifecycle, establishing a shared framework to support innovation, ...
Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening potential candidates, designing drug molecules ...
Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the best US stocks to buy under $50. On January 12, Viking Therapeutics, ...
Straight Arrow News on MSN
Drug company discontinues next-gen flu vaccine development as flu cases rise
French drug company Sanofi announced it's discontinuing research and development for its next-generation mRNA flu vaccine.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results